{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T07:41:36Z","timestamp":1767339696327},"reference-count":35,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T00:00:00Z","timestamp":1268179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergy"],"published-print":{"date-parts":[[2010,9]]},"abstract":"<jats:sec><jats:label \/><jats:p> <jats:bold>To cite this article:<\/jats:bold> D\u00f6lle S, Hoser D, Rasche C, Loddenkemper C, Maurer M, Zuberbier T, Worm M. Long\u2010term reduction in local inflammation by a lipid raft molecule in atopic dermatitis. <jats:italic>Allergy<\/jats:italic> 2010; <jats:bold>65<\/jats:bold>: 1158\u20131165.<\/jats:p><\/jats:sec><jats:sec><jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background:\u2002<\/jats:bold> The complex pathogenesis of atopic dermatitis (AD) is guided by cell surface receptor\u2010mediated signal transduction regulated in lipid rafts. Miltefosine is a raft\u2010modulating molecule targeting cell membranes. With this controlled clinical study, the clinical and immunomodulatory efficacy of miltefosine was investigated in patients with AD in comparison with a topical corticosteroid treatment.<\/jats:p><jats:p><jats:bold>Methods:\u2002<\/jats:bold> Sixteen patients with AD were treated topically with miltefosine and hydrocortisone localized on representative AD target lesions for 3\u2003weeks. To assess the clinical efficacy, the three item severity (TIS) score was evaluated before, during and after treatment as well as after 4\u2010week\u2010follow\u2010up period. To study the anti\u2010inflammatory effect of miltefosine on the cellular T cell pattern, skin biopsies were analysed before and after treatment.<\/jats:p><jats:p><jats:bold>Results:\u2002<\/jats:bold> The TIS score dropped in both groups significantly after treatment. A carry\u2010over effect was exclusively seen for miltefosine after discontinuing the treatment. These findings were substantiated by thermographic imaging with a significant decrease in the maximum temperature (<jats:italic>T<\/jats:italic><jats:sub>max<\/jats:sub>) after miltefosine application (<jats:italic>P<\/jats:italic>\u2003=\u20030.034, \u0394T<jats:sub>max<\/jats:sub>\u2003=\u20031.7\u00b0C [2.1\u20133.9]). Immunohistochemically, a reduction in lesional CD4<jats:sup>+<\/jats:sup>\u2010infiltrating T cells was observed in both treatments. Moreover, increased FoxP3<jats:sup>+<\/jats:sup> cells were present in the skin after miltefosine treatment (before 5.4% [1.9\u20139.8], after 6.2% [3.5\u20139.5]).<\/jats:p><jats:p><jats:bold>Conclusion:\u2002<\/jats:bold> We demonstrate that miltefosine is locally active in patients with AD and led to a sustained clinical improvement in local skin inflammation. Moreover, the increased frequency of FoxP3<jats:sup>+<\/jats:sup> cells in the skin of patients with AD suggests its immunomodulatory properties.<\/jats:p><\/jats:sec>","DOI":"10.1111\/j.1398-9995.2010.02341.x","type":"journal-article","created":{"date-parts":[[2010,3,10]],"date-time":"2010-03-10T17:09:38Z","timestamp":1268240978000},"page":"1158-1165","source":"Crossref","is-referenced-by-count":21,"title":["Long\u2010term reduction in local inflammation by a lipid raft molecule in atopic dermatitis"],"prefix":"10.1111","volume":"65","author":[{"given":"S.","family":"D\u00f6lle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Hoser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Rasche","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Loddenkemper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Zuberbier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Worm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2010,8,4]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2006.03.045"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.84"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.08430.x"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1006\/smim.2000.0301"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.M600485-JLR200"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0005-2760(97)00163-X"},{"key":"e_1_2_7_8_2","doi-asserted-by":"publisher","DOI":"10.2174\/138161208785294636"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-07-0202"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF02536578"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.36.8.1630"},{"key":"e_1_2_7_12_2","first-page":"394","article-title":"Availability of miltefosine for the treatment of kala\u2010azar in India","volume":"83","author":"Sundar S","year":"2005","journal-title":"Bull World Health Organ"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.trstmh.2006.02.022"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)67629-5"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(92)90135-C"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1086\/315268"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2008.248"},{"key":"e_1_2_7_18_2","first-page":"663","article-title":"Diagnostic features of atopic dermatitis","volume":"113","author":"Hanifin J","year":"1980","journal-title":"Arch Dermatol"},{"key":"e_1_2_7_19_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247298"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1080\/000155599750010256"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2007.01363.x"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2006.02647.x"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2004.22621.x"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2009.03.032"},{"key":"e_1_2_7_25_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1978.tb03579.x"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.71"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-02-002873"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2008.08504.x"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2009.09035.x"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1016\/0008-8749(91)90072-J"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2007.08.044"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/nri2474"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2007.00284.x"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-006-9034-2"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2005.01.010"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1186\/1742-4690-5-11"}],"container-title":["Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1398-9995.2010.02341.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1398-9995.2010.02341.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T15:26:23Z","timestamp":1698765983000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1398-9995.2010.02341.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,4]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["10.1111\/j.1398-9995.2010.02341.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1398-9995.2010.02341.x","archive":["Portico"],"relation":{},"ISSN":["0105-4538","1398-9995"],"issn-type":[{"value":"0105-4538","type":"print"},{"value":"1398-9995","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,4]]}}}